A new market research report on
the Global Next Generation Sequencing (NGS) market has introduced by KD
Market Insights. The report is dedicated to in-depth industry analysis of
the global Next Generation Sequencing (NGS) market. The Global Next Generation
Sequencing (NGS) analysis is broken
down on different segmentation levels including Market By Product, By Application, By Technology, By End User.
The global next generation sequencing market size
was valued at $4,533 million in 2018, and is estimated to reach $18,565 million
by 2026, growing at a CAGR of 19.2% from
2019 to 2026.
Next
generation sequencing (NGS) is a novel procedure for sequencing genomes at low
costs and high speed with improved efficiency. NGS also known as deep
sequencing and parallel sequencing is a technology that has revolutionized
molecular biology and genomics research. It is a high throughput, non-Sanger
based sequencing method. Next generation sequencing has made sequencing of
genomes very rapid and cost-effective. Through this method, billions of DNA
strands can be sequenced efficiently. Next generation sequencing has made it
possible to conveniently sequence whole genomes, and analyze various
DNA-protein interactions. This technique allows the researcher to focus, study,
and interpret deep sequence target regions. Next generation sequencing can be
utilized through varied interventions such as oncology, biomarker studies, drug
discovery, understanding reproductive health, and personalized genomics.
Technological advancements in sequencing platforms, surge in
applications of next generation sequencing, and increase in genome mapping
programs drive the growth of the global next generation sequencing market. In
addition, rise in awareness pertaining to next generation sequencing and
increase in investment in research, development, and innovation supplement the
market growth. However, lack of skilled professionals, ethical & legal
limitation related to next generation sequencing, and standardization concerns
in sequencing procedures impede the market growth. Furthermore, use of cloud
computing as a potential data management service and untapped emerging
economies offer lucrative opportunities for the market players.
The next
generation sequencing market is segmented based on
product, application, technology, end user, and region. Based on product, the
market is divided into consumables, platforms, and services. The consumables
product segment is further bifurcated as sample preparation consumables and other
consumables. The sample preparation consumables are further segmented into DNA
fragmentation, end repair, A-Tailing & size selection, library preparation
& target enrichment, and quality control. The platform NGS product segment
is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel
System, and other sequencing platforms. The services segment is divided into
sequencing services and data management services. The sequencing services is
further divided into RNA Sequencing, Whole Exome Sequencing, Whole Genome
Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and
Methyl Sequencing. The data management services further divided into NGS data
analysis services, NGS data analysis software & workbenches, and NGS
storage, management & cloud computing solutions. Based on application, the
market is divided into diagnostics, biomarkers and cancer, reproductive health,
personalized medicine, agriculture and animal research, other applications. By
Technology, market is segmented into sequencing by synthesis, ion semiconductor
sequencing, sequencing by ligation, pyrosequencing, single molecule real time
sequencing, and other technologies. Depends on end user, market is categorized
into academic & clinical research centers, pharmaceutical &
biotechnology companies, hospitals & clinics, and other end user. Based on
region, the market is analyzed across North America, Europe, Asia-Pacific, and
LAMEA.
Based
on region, the market is analyzed across North America, Europe, Asia-Pacific,
and LAMEA. North America accounted for the largest market share in the next
generation sequencing market in 2015, and is expected to retain its dominance
throughout the forecast period. This is primarily attributed to higher buying
power, availability, and applications that favor the utilization of NGS in this
region. There is also an increase in agreements and collaborations between
different market players and health centers to promote and utilize NGS in this
region. However, Asia-Pacific is expected to emerge as a lucrative area with
maximum growth potential, owing to the improvement in R&D facilities,
available disposable income, and rapidly developing economic conditions.
Product
development is the key strategy adopted by market players. The report provides
a comprehensive analysis of the key players that operate in the global next
generation sequencing market.
KEY MARKET BENEFITS
- The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product type assists in understanding the trends in the industry.
- Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
- The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product type assists in understanding the trends in the industry.
- Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
- Consumables
- - Sample Preparation Consumables
- - - - DNA Fragmentation, End Repair, A-Tailing and Size Selection
- - - - Library Preparation & Target Enrichment
- - - - Quality Control
- - Other Consumables
- Platforms
- - HiSeq
- - MiSeq
- - Ion Torrent
- - SOLiD
- - Pacbio Rs II and Sequel System
- - Other Sequencing Platforms
- Services
- - Sequencing Services
- - - - RNA Sequencing
- - - - Whole Exome Sequencing
- - - - Whole Genome Sequencing
- - - - Targeted Sequencing
- - - - Chip Sequencing
- - - - De Novo Sequencing
- - - - Methyl Sequencing
- - Data Management Services
- - - - NGS Data Analysis Services
- - - - NGS Data Analysis Software & Workbenches
- - - - NGS Storage, Management and Cloud Computing Solutions
- Consumables
- - Sample Preparation Consumables
- - - - DNA Fragmentation, End Repair, A-Tailing and Size Selection
- - - - Library Preparation & Target Enrichment
- - - - Quality Control
- - Other Consumables
- Platforms
- - HiSeq
- - MiSeq
- - Ion Torrent
- - SOLiD
- - Pacbio Rs II and Sequel System
- - Other Sequencing Platforms
- Services
- - Sequencing Services
- - - - RNA Sequencing
- - - - Whole Exome Sequencing
- - - - Whole Genome Sequencing
- - - - Targeted Sequencing
- - - - Chip Sequencing
- - - - De Novo Sequencing
- - - - Methyl Sequencing
- - Data Management Services
- - - - NGS Data Analysis Services
- - - - NGS Data Analysis Software & Workbenches
- - - - NGS Storage, Management and Cloud Computing Solutions
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Other Technologies
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Other Technologies
By End User
- Academic and Clinical Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Other End User
- Academic and Clinical Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Other End User
By Region
- North America
- - U.S.
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Spain
- - Rest of Europe
- Asia-Pacific
- - Japan
- - China
- - Australia
- - India
- - South Korea
- - Taiwan
- - Rest of Asia-Pacific
- LAMEA
- - Brazil
- - Turkey
- - Saudi Arabia
- - South Africa
- - Rest of LAMEA
- North America
- - U.S.
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Spain
- - Rest of Europe
- Asia-Pacific
- - Japan
- - China
- - Australia
- - India
- - South Korea
- - Taiwan
- - Rest of Asia-Pacific
- LAMEA
- - Brazil
- - Turkey
- - Saudi Arabia
- - South Africa
- - Rest of LAMEA
KEY PLAYERS PROFILED
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Beijing Genomics Institute
- Qiagen N.V.
- 454 Life Sciences Corporation (Roche Holding AG)
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Genomatix GmbH
- PierianDx
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Beijing Genomics Institute
- Qiagen N.V.
- 454 Life Sciences Corporation (Roche Holding AG)
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Genomatix GmbH
- PierianDx
Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/next-generation-sequencing-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1.
Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1.
Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.
CXO perspective
2.2. Key findings
2.2. Key findings
2.2.1.
Top impacting factors
2.2.2. Top investment pockets
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1.
Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Next generation sequencing Market
3.2. Parent Market Overview
3.3. Key Forces Shaping Next generation sequencing Market
3.3.1.
Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4.
Pricing Analysis
3.4.1.
Pricing Analysis, By Region, 2018 & 2026
3.5.
Market Evolution
3.6. Value Chain Analysis
3.7. Impact of Government Regulations on Global Next Generation Sequencing Market
3.8. Patent Analysis (2016-2018)
3.6. Value Chain Analysis
3.7. Impact of Government Regulations on Global Next Generation Sequencing Market
3.8. Patent Analysis (2016-2018)
3.8.1.
Patent Analysis, by Year
3.8.2. By Country
3.8.3. By Applicant
3.8.2. By Country
3.8.3. By Applicant
3.9.
Case Studies
3.9.1.
Case Study 01
3.10.
Market dynamics
3.10.1.
Drivers
3.10.1.1.
Technological advancements in NGS
3.10.1.2. Surge in applications of NGS
3.10.1.3. Increase in partnerships and collaborations
3.10.1.4. Increase in genome mapping programs
3.10.1.2. Surge in applications of NGS
3.10.1.3. Increase in partnerships and collaborations
3.10.1.4. Increase in genome mapping programs
3.10.2.
Restraints
3.10.2.1.
Standardization concerns over NGS based diagnostics
3.10.2.2. Lack of skilled professionals
3.10.2.3. Ethical and legal limitations
3.10.2.2. Lack of skilled professionals
3.10.2.3. Ethical and legal limitations
3.10.3.
Opportunities
3.10.3.1.
Lucrative opportunities in emerging markets
3.10.3.2. Cloud computing: potential data management service
3.10.3.2. Cloud computing: potential data management service
CHAPTER 4: NEXT GENERATION
SEQUENCING MARKET, BY PRODUCT
4.1.
Overview
4.2. Market size and forecast
4.3. Consumables
4.2. Market size and forecast
4.3. Consumables
4.3.1.
Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2. Market size and forecast, by type
4.3.2.1.
Sample preparation consumables
4.3.2.1.1.
Market size and forecast, by type
4.3.2.1.1.1.
DNA Fragmentation, End Repair, A-Tailing and Size Selection
4.3.2.1.1.1.1.
Market size and forecast
4.3.2.1.1.2.
Library preparation & target enrichment
4.3.2.1.1.2.1.
Market size and forecast
4.3.2.1.1.3.
Quality Control
4.3.2.1.1.3.1.
Market size and forecast
4.3.2.2.
Other Consumables
4.3.2.2.1.
Market size and forecast
4.3.3.
Market size and forecast, by region
4.3.4. Market analysis by country
4.3.4. Market analysis by country
4.4.
Platforms
4.4.1.
Key market trends, growth factors, and opportunities
Continue @...
About Us:
KD Market
Insights offers a
comprehensive database of syndicated research studies, customized reports, and
consulting services. These reports are created to help in making smart, instant
and crucial decisions based on extensive and in-depth quantitative information,
supported by extensive analysis and industry insights. Our dedicated in-house
team ensures the reports satisfy the requirement of the client. We aim at
providing value service to our clients. Our reports are backed by extensive
industry coverage and is made sure to give importance to the specific needs of
our clients. The main idea is to enable our clients to make an informed
decision, by keeping them and ourselves up to date with the latest trends in
the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
No comments:
Post a Comment